AzTrials
AzTrials

Open Heart SurgeryNCT05715060

Sternal Closure in Children After Cardiac Surgery

A study testing Median sternotomy closure (sternal closure) in people with Open Heart Surgery, run by Assiut University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

comparison between stainless steel wires and PDS in closure of sternum in children after cardiac surgery in terms of sternal dehiscence, infection \& cosmetic outcome Read more about this study

Who is it for?
Ages Up to 5 years
Conditions the study is for
Open Heart Surgery
What is being tested?
Median sternotomy closure (sternal closure)
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
45 participants
Where
1 siteEgypt
Study dates
Mar 2023to Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 5 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Infants \& children up to 5 years old underwent open heart surgery in Assiut University heart hospital

Who cannot join

  • Older than 5 years old

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Assiut University heart hospital

    Asyut, 71511

Other trials in Egypt

About this study

Official title: Stainless Steel Wire vs. Polydioxanone "PDS" at Sternal Closure in Children After Cardiac Surgery

comparison between stainless steel wires and PDS in closure of sternum in children after cardiac surgery in terms of sternal dehiscence, infection \& cosmetic outcome

Read the detailed description

Median sternotomy is considered to be the gold standard incision in cardiac surgery. Sternotomy has to be performed properly to avoid short- and long-term morbidity and mortality. The surgical technique is well established and certain principles are recognized to be crucial to minimize complications. The identification of the correct landmarks, midline tissue preparation, osteotomy with the avoidance of injury to underlying structures like pleura, pericardium and ectatic ascending aorta, and targeted bleeding control are important steps of the procedure. As important as the performance of a proper sternotomy is a correct sternal closure. An override or shift of the sternal edges has to be avoided by placing the wires at a proper distance from each other without injuring the thoracic pedicle. The two sternal halves have to be tightly re-approximated to facilitate healing of the bone and to avoid instability, which is a risk factor for wound infection. With a proper performance of sternotomy and sternal closure, instability and wound infections are rare and depend on patient-related risk factors . Conventional closure uses stainless steel wire sutures which may not be the ideal approach as sternal wound infection and mediastinitis are troublesome complications following this method which are major causes of morbidity and mortality of patients. Availability of delayed absorbable sutures such as polydioxanone sutures (PDS) for sternal closure allows us to test the efficacy of it in prevention of these complications.

Being tested
Median sternotomy closure (sternal closure)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Median sternotomy closure (sternal closure)Procedure or surgery

    Comparison of Sternal closure after cardiac surgery between conventional way which is by stainless steel wire \& Polydioxanone (PDS)

Study groups in NCT05715060
Study groupRoleWhat they receive
stainless steel wire closureActive comparatorconventional closure of median sternotomy by stainless steel wire
Receives: Procedure: Median sternotomy closure (sternal closure)
PDS sternal closureActive comparatorclosure of median sternotomy by PDS
Receives: Procedure: Median sternotomy closure (sternal closure)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Sternal stability

    Comparison of incidence of sternal dehiscence \& instability between 2 groups this is done by clinical assessment(history \& examination) \& follow up chest x-rays

    Measured: up to 2 years

Secondary outcomes (2)
  1. cosmetic outcome (prominent wire)

    calculation and observation of prominent wire incidence in patients closed with stainless steel wire Done by clinical assessment(history \& examination)

    Measured: up to 2 years

  2. Wound infection

    comparison of incidence of skin infection between 2 groups Done by clinical assessment(history \& examination)

    Measured: up to 2 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Feb 2023
  2. Study startMar 2023 (estimated)
  3. Primary completionJun 2024 (estimated)
  4. Study completionDec 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
45 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05715060
Sponsor's protocol ID
sternal closure in children
Status last verified
Feb 2023
First submitted
8 Nov 2022
Last updated
6 Feb 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Median sternotomy closure (sternal closure) in people with Open Heart Surgery, run by Assiut University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 6 Feb 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Sternal stability (time frame: up to 2 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Feb 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in